A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.
NCT00549055
·
clinicaltrials.gov ↗
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration
Interventions
DRUG:
Macugen
Sponsor
Pfizer